vs
Cooper Companies (The)（COO）与Globe Life（GL）财务数据对比。点击上方公司名可切换其他公司
Globe Life的季度营收约是Cooper Companies (The)的1.5倍（$1.6B vs $1.1B），Globe Life净利率更高（17.3% vs 7.9%，领先9.4%），Globe Life同比增速更快（5.3% vs 4.6%），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 4.1%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
Globe Life Inc.（股票代码：GL）是总部位于美国得克萨斯州麦金尼的金融服务控股公司，在纽约证券交易所上市，通过旗下全资子公司开展业务，主营人寿保险、年金产品及补充健康保险产品。
COO vs GL — 直观对比
营收规模更大
GL
是对方的1.5倍
$1.1B
营收增速更快
GL
高出0.8%
4.6%
净利率更高
GL
高出9.4%
7.9%
两年增速更快
COO
近两年复合增速
4.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.6B |
| 净利润 | $84.6M | $270.5M |
| 毛利率 | 61.1% | — |
| 营业利润率 | 13.2% | — |
| 净利率 | 7.9% | 17.3% |
| 营收同比 | 4.6% | 5.3% |
| 净利润同比 | -28.0% | 6.3% |
| 每股收益（稀释后） | $0.42 | $3.39 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOGL
| Q1 26 | — | $1.6B | ||
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $1.5B | ||
| Q2 25 | $1.0B | $1.5B | ||
| Q1 25 | $964.7M | $1.5B | ||
| Q4 24 | $1.0B | $1.5B | ||
| Q3 24 | $1.0B | $1.5B | ||
| Q2 24 | $942.6M | $1.4B |
净利润COOGL
| Q1 26 | — | $270.5M | ||
| Q4 25 | $84.6M | $266.1M | ||
| Q3 25 | $98.3M | $387.8M | ||
| Q2 25 | $87.7M | $252.7M | ||
| Q1 25 | $104.3M | $254.6M | ||
| Q4 24 | $117.5M | $255.2M | ||
| Q3 24 | $104.7M | $303.0M | ||
| Q2 24 | $88.9M | $258.4M |
毛利率COOGL
| Q1 26 | — | — | ||
| Q4 25 | 61.1% | — | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | — | ||
| Q1 25 | 68.4% | — | ||
| Q4 24 | 66.5% | — | ||
| Q3 24 | 66.1% | 26.1% | ||
| Q2 24 | 67.0% | 23.3% |
营业利润率COOGL
| Q1 26 | — | — | ||
| Q4 25 | 13.2% | 21.7% | ||
| Q3 25 | 16.6% | 31.5% | ||
| Q2 25 | 18.4% | 21.2% | ||
| Q1 25 | 18.9% | 21.4% | ||
| Q4 24 | 19.5% | 21.3% | ||
| Q3 24 | 19.2% | 26.3% | ||
| Q2 24 | 17.2% | 23.5% |
净利率COOGL
| Q1 26 | — | 17.3% | ||
| Q4 25 | 7.9% | 17.5% | ||
| Q3 25 | 9.3% | 25.6% | ||
| Q2 25 | 8.7% | 17.1% | ||
| Q1 25 | 10.8% | 17.2% | ||
| Q4 24 | 11.5% | 17.4% | ||
| Q3 24 | 10.4% | 20.8% | ||
| Q2 24 | 9.4% | 17.9% |
每股收益（稀释后）COOGL
| Q1 26 | — | $3.39 | ||
| Q4 25 | $0.42 | $3.28 | ||
| Q3 25 | $0.49 | $4.73 | ||
| Q2 25 | $0.44 | $3.05 | ||
| Q1 25 | $0.52 | $3.01 | ||
| Q4 24 | $0.59 | $3.00 | ||
| Q3 24 | $0.52 | $3.44 | ||
| Q2 24 | $0.44 | $2.83 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $183.8M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $8.2B | $6.1B |
| 总资产 | $12.4B | — |
| 负债/权益比越低杠杆越低 | 0.30× | — |
8季度趋势，按日历期对齐
现金及短期投资COOGL
| Q1 26 | — | $183.8M | ||
| Q4 25 | $110.6M | $314.7M | ||
| Q3 25 | $124.9M | $62.8M | ||
| Q2 25 | $116.2M | $116.7M | ||
| Q1 25 | $100.9M | $134.1M | ||
| Q4 24 | $107.6M | $85.0M | ||
| Q3 24 | $109.7M | $100.5M | ||
| Q2 24 | $112.4M | $100.6M |
总债务COOGL
| Q1 26 | — | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — |
股东权益COOGL
| Q1 26 | — | $6.1B | ||
| Q4 25 | $8.2B | $6.0B | ||
| Q3 25 | $8.4B | $5.7B | ||
| Q2 25 | $8.3B | $5.4B | ||
| Q1 25 | $8.1B | $5.4B | ||
| Q4 24 | $8.1B | $5.3B | ||
| Q3 24 | $7.9B | $4.6B | ||
| Q2 24 | $7.8B | $5.2B |
总资产COOGL
| Q1 26 | — | — | ||
| Q4 25 | $12.4B | $30.8B | ||
| Q3 25 | $12.4B | $30.5B | ||
| Q2 25 | $12.4B | $29.8B | ||
| Q1 25 | $12.2B | $29.7B | ||
| Q4 24 | $12.3B | $29.1B | ||
| Q3 24 | $12.1B | $29.6B | ||
| Q2 24 | $12.0B | $28.3B |
负债/权益比COOGL
| Q1 26 | — | — | ||
| Q4 25 | 0.30× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | — |
| 自由现金流经营现金流 - 资本支出 | $149.9M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 9.2% | — |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COOGL
| Q1 26 | — | — | ||
| Q4 25 | $247.9M | $350.6M | ||
| Q3 25 | $261.4M | $306.0M | ||
| Q2 25 | $96.2M | $307.9M | ||
| Q1 25 | $190.6M | $431.9M | ||
| Q4 24 | $268.1M | $336.9M | ||
| Q3 24 | $207.5M | $340.6M | ||
| Q2 24 | $111.0M | $374.1M |
自由现金流COOGL
| Q1 26 | — | — | ||
| Q4 25 | $149.9M | $330.1M | ||
| Q3 25 | $164.5M | $208.7M | ||
| Q2 25 | $18.1M | $295.0M | ||
| Q1 25 | $101.2M | $420.1M | ||
| Q4 24 | $128.1M | $321.9M | ||
| Q3 24 | $118.5M | $311.3M | ||
| Q2 24 | $36.9M | $356.5M |
自由现金流率COOGL
| Q1 26 | — | — | ||
| Q4 25 | 14.1% | 21.7% | ||
| Q3 25 | 15.5% | 13.8% | ||
| Q2 25 | 1.8% | 19.9% | ||
| Q1 25 | 10.5% | 28.4% | ||
| Q4 24 | 12.6% | 22.0% | ||
| Q3 24 | 11.8% | 21.4% | ||
| Q2 24 | 3.9% | 24.8% |
资本支出强度COOGL
| Q1 26 | — | — | ||
| Q4 25 | 9.2% | 1.3% | ||
| Q3 25 | 9.1% | 6.4% | ||
| Q2 25 | 7.8% | 0.9% | ||
| Q1 25 | 9.3% | 0.8% | ||
| Q4 24 | 13.7% | 1.0% | ||
| Q3 24 | 8.9% | 2.0% | ||
| Q2 24 | 7.9% | 1.2% |
现金转化率COOGL
| Q1 26 | — | — | ||
| Q4 25 | 2.93× | 1.32× | ||
| Q3 25 | 2.66× | 0.79× | ||
| Q2 25 | 1.10× | 1.22× | ||
| Q1 25 | 1.83× | 1.70× | ||
| Q4 24 | 2.28× | 1.32× | ||
| Q3 24 | 1.98× | 1.12× | ||
| Q2 24 | 1.25× | 1.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
GL
| Life premium | $853.2M | 55% |
| Health premium | $416.9M | 27% |
| Other | $289.5M | 19% |
